Selective lymphopenia in man after intralymphatic injection of radioactive 131-I lipiodol.
نویسندگان
چکیده
Bloom, H. J. G. (1950). Brit. 7. Cancer, 4, 259, 347. Richardson, W. W., and Harries, E. J. (1962). Brit. med. 7., 2, 213. Hodnett, E. M. (1963). Cancer Chemother. Rep., No. 32, p. 55. Horwitz, H. (1960). Brit. 7. Radiol., 33, 659. International Union Against Cancer (1959). Ibid., 32, 824. Kreyberg, L., and Christiansen T. (1953). Brit. 7. Cancer, 7, 37. McWhirter, R. (1954). Brit. Y. Radiol., 27, 649. (1955). Ibid., 28, 128. (1957). 7. Fac. Radiol. (Lond.), 8, 220. Moore, G. E., Sandberg, A. A., and Watne, A. L. (1960). 7. Aner. med. Ass., 172, 1729. Park, W. W., and Lees, J. C. (1951). Surg. Gynec. Obstet., 93, 129. Paterson, R., and Russell, M. H. (1959). 7. Fac. Radiol. (Land.), 10, 175. (1959). Ibid., 10, 130. Philip, J. F. (1949). Malignant Disease. Aberdeen. Riddel, V. H. (1950). Brit. 7. Cancer, 4, 289. Smithers, D. W. (1952). 7. Fac. Radiol. (Lond.), 4, 89. Watson, T. A. (1959). Lancet, 1, 1191.
منابع مشابه
Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
HYPOTHESIS Intra-arterial lipiodol labeled with iodine 131 ((131)I-lipiodol) can be safely used as adjuvant therapy following curative liver resection for hepatocellular carcinoma (HCC). DESIGN Phase 2 pilot study. SETTING Large teaching hospital. PATIENTS Twenty-eight patients (24 men and 4 women; median age, 61.5 years; range, 33-75 years) were treated from January 1991 to June 1997. Th...
متن کاملAdjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up.
UNLABELLED Recurrences after resection of hepatocellular carcinoma are frequent. A single postoperative injection of (131)I-labeled lipiodol in the hepatic artery was shown in 1999 by Lau and colleagues to be an effective adjuvant treatment, and those results were strengthened by our experience with a case-control study, reported in 2003. The goal of this paper is to update the 2003 results for...
متن کاملAdjuvant Intraarterial Lipiodol or ¹³¹I-Lipiodol After Curative Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial.
UNLABELLED The prevention of tumor recurrence after curative treatment of hepatocellular carcinoma (HCC) is unresolved. Postoperative intraarterial injection of (131)I-labeled lipiodol has been proposed as adjuvant treatment. The aim of this prospective randomized trial was to evaluate if a single dose of postoperative adjuvant intraarterial (131)I-lipiodol (vs. unlabeled lipiodol) could reduce...
متن کاملTransarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
UNLABELLED Transarterial chemoembolization (TACE) improves survival in patients with hepatocellular carcinoma (HCC) in whom curative therapies are not suitable. The aim of this study was to assess survival differences in patients with hepatic cirrhosis and unresectable HCC treated by (131)I-lipiodol versus TACE or transarterial embolization (TAE). METHODS A retrospective study was performed o...
متن کاملAdjuvant Iodine131 Lipiodol after Resection of Hepatocellular Carcinoma
Background. Survival after liver resection for HCC is compromised by a high rate of intrahepatic recurrence. Adjuvant treatment with a single, postoperative dose of intra-arterial I(131) lipiodol has shown promise, as a means of prolonging disease-free survival (DFS). Methodology. DFS and overall survival (OS) after a single dose of postoperative I(131) lipiodol were compared to liver resection...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- British medical journal
دوره 1 5536 شماره
صفحات -
تاریخ انتشار 1967